VEGFA and neoplasm: We have previously reported that an anti-VEGF antibody or sunitinib, a tyrosine kinase inhibitor that targets the VEGF receptor, inhibited tumor angiogenesis and vascular structures of endocrine organs such as the thyroid, which was correlated with the appearance of hypothyroidism.5